cropped-REPRIEVE-Logo-Web4.pngcropped-REPRIEVE-Logo-Web4.pngcropped-REPRIEVE-Logo-Web4.pngcropped-REPRIEVE-Logo-Web4.png
  • About REPRIEVE
    • Spread the Word about REPRIEVE!
    • Our Story
    • Publications
    • In the News
    • Study FAQ
  • Meet Our Team
    • Clinical Coordinating Center (CCC)
    • Data Coordinating Center (DCC)
    • REPRIEVE Site Teams
    • Community Scientific Subcommittee (CSS)
    • REPRIEVE Community Advisory Board (CAB)
    • National Institutes of Health
  • For Participants
    • REPRIEVE 2023 Community Forums
    • Statin Use After REPRIEVE
    • Meet REPRIEVE Participants
    • My Matters Blog
    • Participant Newsletter
    • Recursos en Español
      • Preguntas Más Frecuentes
      • Mapa de Centros de Investigación Clínica
      • Gacetilla Para Participantes N° 1
  • Our Sites
  • Site Resources
    • REPRIEVE Site Newsletters
    • Ancillary Studies
  • My Matters Blog
  • Contact Us
✕

For Participants

  • REPRIEVE Community Forum

  • Statin Use After REPRIEVE

  • Meet REPRIEVE Participants

  • My Heart Matters Blog

  • Participant Newsletter

  • Recursos en Español

Search

✕
 

Recent News

  • World AIDS Day: Research from Across Mass General Brigham
    November 30, 2023
  • Use of statins in individuals with HIV and low cardiovascular risk: the next stop along the route to optimized risk management
    November 16, 2023
©2019 | This website, and any related materials applies only to REPRIEVE A5332. See list of participating sites here.